Therapeutic strategies in migraine patients with mood and anxiety disorders: Clinical evidence

Neurological Sciences

Volumn 31, Issue SUPPL.1, 2010, Pages

  Finocchi, Cinzia ^a   Villani, Veronica ^b   Casucci, Gerardo ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Casa di Cura S Francesco   (Italy)

Author keywords

Allodynia; Anxiety; Depression; Migraine; Therapy

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUNARIZINE; LAMOTRIGINE; NORADRENALIN UPTAKE INHIBITOR; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; VALPROATE SEMISODIUM; ANXIOLYTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ALLODYNIA; ANXIETY; ANXIETY DISORDER; BIPOLAR DEPRESSION; COGNITIVE THERAPY; COMORBIDITY; CONFERENCE PAPER; CUTANEOUS ALLODYNIA; DEPRESSION; DRUG INDICATION; EPISODIC MIGRAINE; FIBROMYALGIA; HUMAN; MAJOR DEPRESSION; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MOOD DISORDER; PRIMARY HEADACHE; QUALITY OF LIFE; TRANSFORMED MIGRAINE; VAGUS NERVE STIMULATION; PRACTICE GUIDELINE; REVIEW;

ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; HUMANS; MIGRAINE DISORDERS; MOOD DISORDERS; PRACTICE GUIDELINES AS TOPIC; SEROTONIN UPTAKE INHIBITORS;

EID: 77955862797     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-010-0297-2     Document Type: Conference Paper

References (29)

1. Radat F, Swendsen J (2004) Psychiatric comorbidity in migraine: A review. Cephalalgia 25:165-178 (Pubitemid 40321708)
2. Lake AE, Rains JC, Penzien DB, Lipchik GL (2005) Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache 45:493-506 (Pubitemid 40847172)
3. Hamelsky SW, Lipton RB (2006) Psychiatric comorbidity of migraine. Headache 46:1327-1333 (Pubitemid 44556425)
4. Breslau N, Davis GC, Andreski P (1991) Migraine, psychiatric disorders, and suicide attempts: An epidemiologic study of young adults. Psychiatry Res 137:11-23
5. Baskin SM, Todd A, Smitherman A (2009) Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications. Neurol Sci 30(Suppl 1):S61-S65
6. Bigal M, Lipton RB (2009) What predicts the change from episodic to chronic migraine? Curr Opin Neurol 22:269-276
7. Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, Drexler E, Martin VT, Hutchinson S, Aurora SK, Recober A, Herial NA, Hutley C, White L, Khunder SA (2009) Allodynia in migraine: Association with comorbid pain conditions. Headache 49:1333-1344
8. Scher AI, Lipton RB, Stewart WF (2003) Habitual snoring as a risk factor for chronic daily headache. Neurology 60:1366-1368 (Pubitemid 36460999)
9. Bigal ME, Ashina S, Burstein R (2008) Prevalence and characteristics of allodynia in headache sufferers: A population study. Neurology 70:1525-1533 (Pubitemid 351589506)
10. Heckman BD, Holroyd KA, Himawan L, O'Donnell FJ, Tietjen G, Utley C, Stillman M (2009) Do psychiatric comorbidities influence headache treatment outcomes? Results of a naturalistic longitudinal treatment study. Pain 146:56-64
11. Krymchantowski AV, Bryson J, Lipton RB, Bigal ME (2008) Neuromodulators for the treatment of headache disorders and fibromyalgia. Curr Pain Headache Rep 12(5):333-337
12. Calandre EP, Garcia-Leiva JM, Rico-Villademoros F, Vilchez JS, Rodriguez-Lopez CM (2010) Pregabalin in the treatment of chronic migraine: An open-label study. Clin Neuropharmacol 33(1):35-39
13. Maidment ID (2002) The use of topiramate in mood stabilization. Ann Pharmacother 36(7-8):1277-1281 (Pubitemid 34755808)
14. Frye M, Ketter T, Kimbrell T et al (2000) A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 20:607-614
15. Calabrese J, Bowden C, Sachs G et al (2003) A placebocontrolled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 64:1013-1102
16. Klapper J (1997) Divalproex sodium in migraine prophylaxis: A dose-controlled study. Cephalalgia 17:103-108 (Pubitemid 27166264)
17. Vikelis M, Rapoport AM (2010) Role of antiepileptic drugs as preventive agents for migraine. CNS Drugs 24(1):21-33
18. Steiner TJ, Findley LJ, Yuen AW (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17:109-112 (Pubitemid 27166265)
19. D'Andrea G, Granella F, Cadaldini M, Manzoni GC (1997) Effectiveness of lamotrigine in the prophylaxis of migraine with aura: An open pilot study. Cephalalgia 19:64-66
20. Lampl C, Katsarava Z, Diener HC, Limmroth V (2005) Lamotrigin reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 76:1730-1732 (Pubitemid 41697646)
21. Schürks M, Diener HC, Goadsby P (2008) Update on the prophylaxis of migraine. Curr Treat Options Neurol 10(1):20-29
22. Bell IR, Edman JS, Morrow FD, Marby DW, Perrone G, Kayne HL, Greenwald M, Cole JO (1992) Vitamin B1, B2, and B6 augmentation of tricyclic antidepressant treatment in geriatric depression with cognitive dysfunction. Am Coll Nutr 11(2):159-163
23. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2009) Lower plasma Coenzyme Q10 in depression: A marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinol Lett 30(4):462-469
24. Qaseem A, Snow V, Denberg TD, Forciea MA, Owens DK, for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians (2008) Using second-generation antidepressants to treat depressive disorders: A clinical practice guideline from the American College of Physicians. Ann Intern Med 149:725-733
25. NICE guidelines. Anxiety management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. http://guidance.nice.org.uk/CG22
26. WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders- first revision. World J Biol Psychiatry 9(4):248-312
27. Colombo B, Annovazzi POL, Comi G (2004) Therapy of primary headaches: The role of antidepressants. Neurol Sci 25:S171-S175 (Pubitemid 41461986)
28. Evans RW (2007) The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: An analysis of the 29 case reports. MedGenMed 9(3):48
29. Proietti Cecchini A, Mea E, Tullo V, Curone M, Franzini A, Broggi G, Savino M, Bussone G, Leone M (2009) Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data. Neurol Sci 30(Suppl 1):S101-S104